KZRHealthcareNano-Cap
Kezar Life Sciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Kezar Life Sciences, Inc. (KZR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are KZR insiders buying or selling?
Kezar Life Sciences, Inc. insiders reported 26 open-market buys ($30.9M) and 13 sells ($2.8M) across 39 Form 4 filings — a net buying position of $28.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 3, 2025)
Total Form 4 filings
39
SEC EDGAR
Insider filers
12
Insider buys (26)
$30.9M
Insider sells (13)
$2.8M
Insider sentiment
Net buyingNet insider flow of $28.1M in net buying.
Recent KZR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 3, 2025 | Pichi Luo Chiang | SVP, Corporate Controller | Sale | 264 | $4.28 | $1.1K |
| Jul 3, 2025 | Mark C. Schiller | Chief Operating Officer | Sale | 561 | $4.28 | $2.4K |
| Jul 26, 2024 | Mark C. Schiller | Chief Legal Officer | Sale | 6.7K | $0.58 | $3.9K |
| Feb 7, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 65.0K | $6.98 | $454.0K |
| Feb 3, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 90.0K | $7.08 | $637.5K |
| Feb 1, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 60.0K | $7.00 | $419.7K |
| Jan 27, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 50.0K | $6.85 | $342.5K |
| Jan 19, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 6.1K | $6.79 | $41.5K |
| Jan 17, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 7.0K | $6.88 | $47.9K |
| Jan 9, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 15.2K | $6.95 | $105.4K |
| Jan 5, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sale | 55.5K | $7.14 | $396.1K |
| Oct 5, 2022 | Morningside Venture Investments Ltd | 10% Owner | Sale | 32.3K | $8.78 | $283.8K |
| Mar 22, 2022 | Franklin M Berger | Director | Purchase | 80.0K | $16.25 | $1.3M |
| Jan 5, 2022 | Michael Kauffman | Director | Sale | 5.0K | $16.45 | $82.3K |
| Mar 29, 2021 | Vassiliki Economides | SVP, Strategy & External Aff. | Purchase | 750 | $10.19 | $7.6K |
| Jun 15, 2020 | Equal Talent Investments Ltd | 10% Owner | Purchase | 1.5M | $5.50 | $8.0M |
| Jun 11, 2020 | Franklin M Berger | Director | Purchase | 100.0K | $5.50 | $550.0K |
| Feb 6, 2020 | Morningside Venture Investments Ltd | 10% Owner | Purchase | 3.8M | $2.60 | $9.9M |
| Feb 6, 2020 | John Franklin Fowler | CEO | Purchase | 38.5K | $2.60 | $100.0K |
| Feb 6, 2020 | Marc Belsky | CFO | Purchase | 15.4K | $2.60 | $40.0K |
| Feb 6, 2020 | Vassiliki Economides | SVP, Strategy & External Aff. | Purchase | 5.8K | $2.60 | $15.0K |
| Feb 6, 2020 | Franklin M Berger | Director | Purchase | 120.8K | $2.60 | $314.2K |
| Feb 6, 2020 | Christopher J. Kirk | President and CSO | Purchase | 38.5K | $2.60 | $100.0K |
| Nov 14, 2019 | Marc Belsky | CFO | Purchase | 800 | $2.76 | $2.2K |
| Oct 11, 2019 | John Franklin Fowler | CEO | Purchase | 1.0K | $3.24 | $3.2K |
Showing the 25 most recent of 39 Form 4 filings for Kezar Life Sciences, Inc..
Most active KZR insiders
- Morningside Venture Investments Ltd11 filings
- Marc Belsky5 filings
- Vassiliki Economides5 filings
- Franklin M Berger4 filings
- John Franklin Fowler4 filings
Ask anything about KZR insider activity
Use Trabud's AI agent to query Kezar Life Sciences, Inc.'s Form 4 history in plain English — "Show me KZR CEO purchases this year" or compare it against any other ticker.
Open the AI agentKZR insider trading FAQ
Are Kezar Life Sciences, Inc. insiders buying or selling?
Across 39 SEC Form 4 filings, Kezar Life Sciences, Inc. (KZR) insiders reported 26 open-market purchases totaling $30.9M and 13 sales totaling $2.8M. That is a net buying position of $28.1M.
How many insiders trade KZR stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Kezar Life Sciences, Inc.. The most recent filing was accepted on Jul 3, 2025.
Where does Trabud get KZR insider trading data?
All KZR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.